東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Behavioral clinical trials for chron...

Freedland, Kenneth E.

FindBook

Google Book

Amazon

博客來

Behavioral clinical trials for chronic diseases = scientific foundations /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Behavioral clinical trials for chronic diseases/ by Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann.
其他題名:	scientific foundations /
作者:	Powell, Lynda H.
其他作者:	Freedland, Kenneth E.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	xviii, 314 p. :ill., digital ;24 cm.
內容註:	Introduction: the window of opportunity -- A selected history of randomized behavioral clinical trials: what we learned -- A clinically significant problem and a clincially significant benefit -- The process of developing a behavioral treatment for chronic disease -- The hypothesized pathway from behavioral treatment to chronic disease -- Equipoise, blinding, and investigator discipline -- Sensitivity to diversity -- Protection of randomization -- Choice of appropriate control group -- Readiness to conduct a behavioral randomized clinical trial -- Concluding remarks.
Contained By:	Springer Nature eBook
標題:	Chronic diseases - Treatment -
電子資源:	https://doi.org/10.1007/978-3-030-39330-4
ISBN:	9783030393304

Behavioral clinical trials for chronic diseases = scientific foundations /
Powell, Lynda H.

Behavioral clinical trials for chronic diseasesscientific foundations /[electronic resource] :by Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann. - Cham :Springer International Publishing :2021. - xviii, 314 p. :ill., digital ;24 cm.

Introduction: the window of opportunity -- A selected history of randomized behavioral clinical trials: what we learned -- A clinically significant problem and a clincially significant benefit -- The process of developing a behavioral treatment for chronic disease -- The hypothesized pathway from behavioral treatment to chronic disease -- Equipoise, blinding, and investigator discipline -- Sensitivity to diversity -- Protection of randomization -- Choice of appropriate control group -- Readiness to conduct a behavioral randomized clinical trial -- Concluding remarks.

This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to "speak the language of medicine" through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.

ISBN: 9783030393304

Standard No.: 10.1007/978-3-030-39330-4doiSubjects--Topical Terms:

3521467
Chronic diseases
--Treatment

LC Class. No.: RC108 / .P68 2021

Dewey Class. No.: 616.044

Behavioral clinical trials for chronic diseases = scientific foundations /
LDR:03115nmm a2200325 a 4500 001 2253332
003 DE-He213
005 20211013130535.0
006 m d
007 cr nn 008maaau
008 220327s2021 sz s 0 eng d
020 $a 9783030393304 $q (electronic bk.)
020 $a 9783030393281 $q (paper)
024 7 $a 10.1007/978-3-030-39330-4 $2 doi
035 $a 978-3-030-39330-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC108 $b .P68 2021
072 7 $a MBNH9 $2 bicssc
072 7 $a PSY003000 $2 bisacsh
072 7 $a MBNH9 $2 thema
082 0 4 $a 616.044 $2 23
090 $a RC108 $b .P884 2021
100 1 $a Powell, Lynda H. $3 877992
245 1 0 $a Behavioral clinical trials for chronic diseases $h [electronic resource] : $b scientific foundations / $c by Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xviii, 314 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction: the window of opportunity -- A selected history of randomized behavioral clinical trials: what we learned -- A clinically significant problem and a clincially significant benefit -- The process of developing a behavioral treatment for chronic disease -- The hypothesized pathway from behavioral treatment to chronic disease -- Equipoise, blinding, and investigator discipline -- Sensitivity to diversity -- Protection of randomization -- Choice of appropriate control group -- Readiness to conduct a behavioral randomized clinical trial -- Concluding remarks.
520 $a This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to "speak the language of medicine" through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.
650 0 $a Chronic diseases $x Treatment $x Research. $3 3521467
650 0 $a Behavior therapy $x Research. $3 3521468
650 1 4 $a Health Psychology. $3 894227
650 2 4 $a Health Promotion and Disease Prevention. $3 894308
650 2 4 $a Complementary & Alternative Medicine. $3 898583
650 2 4 $a Behavioral Therapy. $3 891330
700 1 $a Freedland, Kenneth E. $3 3521465
700 1 $a Kaufmann, Peter G. $3 3521466
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-39330-4
950 $a Behavioral Science and Psychology (SpringerNature-41168)